BioResearch

Experimental Drug Brings Remission in Eighty Percent of Melanoma Patients
Results obtained in a multicenter clinical study have revealed that treatment of metastatic melanoma with the experimental oral drug PLX4032 in patients with tumors that carry the V600E BRAF mutation resulted in complete or partial tumor regression in nearly 80% of patients. More...08 Sep 2010
In Other News
Limb Regeneration in Mammals Requires Blocking Two Tumor Suppressor Genes
Peptide Mix Makes HIV Self-Destruct in a Petri Dish
Nanoliter Range Liquid-Handling System Now Available to Biotech Researchers
Nanoparticle-Coated T-cells Destroy Tumors in Mouse Model
Nerve Connections Regenerated after Spinal Cord Injury
Bee Venom to Target Cancer Cells
Multifunctional Microplate Reader Now Available
Some Cancers May Be Suppressed by Alphavirus-Based Vaccine
Electrons Seen Moving in Real Time for the First Time
Highly Sensitive Laser Scanning to Advance Antibody Discovery
Emodin Corrects Type II Diabetes Metabolic Imbalance in Mouse Model
Drugs That Target Small RNAs May Alleviate Chronic Pain
The Small Molecule that Might Revolutionize the Treatment of Diabetes
Inhibition of Galectin-3 Prevents New Blood Vessel Formation
A Better Way to Grow Stem Cells
First Step Achieved Towards Electronic DNA Sequencing: Translocation Through Graphene Nanopores
Credit Card-Size Microflow System Designed to Tackle Thousands of Experiments
Gene Manipulations Enable Regeneration of Injured Spinal Tissue
Modeling Genetic Circuitry of Cell-To-Cell Communication with Integrated Fluid Circuit Technology
Process Reveals How Key Enzyme Repairs Sun-Damaged DNA
Magnetic Nanoparticles Kill Tumors with Localized Heat
New Two-Step PCR System Improves Quantification Sensitivity
Development of Liver Cancer Linked to an Inactive Tumor Suppressor Gene
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







